(Q44285325)

English

Gastrodin ameliorates depressive-like behaviors and up-regulates the expression of BDNF in the hippocampus and hippocampal-derived astrocyte of rats

scientific article published on 30 November 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 December 2017

Gastrodin ameliorates depressive-like behaviors and up-regulates the expression of BDNF in the hippocampus and hippocampal-derived astrocyte of rats (English)

1 reference

Europe PubMed Central

1 December 2017

0 references

author name string

Ruiguo Zhang

1

1 reference

Europe PubMed Central

1 December 2017

Zhengwu Peng

2

1 reference

Europe PubMed Central

1 December 2017

Huaihai Wang

3

1 reference

Europe PubMed Central

1 December 2017

Fen Xue

4

1 reference

Europe PubMed Central

1 December 2017

Yihuan Chen

5

1 reference

Europe PubMed Central

1 December 2017

Ying Wang

6

1 reference

Europe PubMed Central

1 December 2017

Huaning Wang

7

1 reference

Europe PubMed Central

1 December 2017

Qingrong Tan

8

1 reference

Europe PubMed Central

1 December 2017

publication date

30 November 2013

1 reference

Europe PubMed Central

1 December 2017

Neurochemical Research

1 reference

Europe PubMed Central

1 December 2017

39

1 reference

Europe PubMed Central

1 December 2017

1

1 reference

Europe PubMed Central

1 December 2017

172-179

1 reference

Europe PubMed Central

1 December 2017

https://scigraph.springernature.com/pub.10.1007/s11064-013-1203-0

0 references

Risk factors for drug nonadherence in antidepressant-treated patients and implications of pharmacist adherence instructions for adherence improvement

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Treatment-resistant depression in adolescents: recognition and management

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Tian ma, an ancient Chinese herb, offers new options for the treatment of epilepsy and other conditions

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Pharmacokinetics of gastrodin and its metabolite p-hydroxybenzyl alcohol in rat blood, brain and bile by microdialysis coupled to LC-MS/MS.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Protective effects of gastrodin on hypoxia-induced toxicity in primary cultures of rat cortical neurons.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Gastrodin protect primary cultured rat hippocampal neurons against amyloid-beta peptide-induced neurotoxicity via ERK1/2-Nrf2 pathway.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

A study of the neuroprotective effect of the phenolic glucoside gastrodin during cerebral ischemia in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Gastrodin inhibits expression of inducible NO synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-stimulated microglia via MAPK pathways

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Anxiolytic-like effects of Gastrodia elata and its phenolic constituents in mice

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Gastrodin and p-hydroxybenzyl alcohol facilitate memory consolidation and retrieval, but not acquisition, on the passive avoidance task in rats

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Protective effects of gastrodin on lead-induced synaptic plasticity deficits in rat hippocampus

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Astrocytes: biology and pathology

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Reactive astrocytes: cellular and molecular cues to biological function

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

A neurotrophic model for stress-related mood disorders

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Role of neurotrophic factors in depression

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Time-dependent changes in BDNF expression of pentylenetetrazole-induced hippocampal astrocytes in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Stress, depression, and anhedonia: caveats concerning animal models

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Communication between neurons and astrocytes: relevance to the modulation of synaptic and network activity

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Antidepressants increase glial cell line-derived neurotrophic factor production through monoamine-independent activation of protein tyrosine kinase and extracellular signal-regulated kinase in glial cells

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Influences of chronic venlafaxine, olanzapine and nicotine on the hippocampal and cortical concentrations of brain-derived neurotrophic factor (BDNF).

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impaired mice

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

A negative regulator of MAP kinase causes depressive behavior

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

N-desalkylquetiapine activates ERK1/2 to induce GDNF release in C6 glioma cells: a putative cellular mechanism for quetiapine as antidepressant

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Using the rat forced swim test to assess antidepressant-like activity in rodents

1 reference

https://api.crossref.org/works/10.1007%2FS11064-013-1203-0

21 January 2018

Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods

1 reference

https://pubmed.ncbi.nlm.nih.gov/24293261

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost burden of treatment resistance in patients with depression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24293261

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amitriptyline versus placebo for major depressive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/24293261

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24293261

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11064-013-1203-0

1 reference

Europe PubMed Central

1 December 2017

1 reference

Europe PubMed Central

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44285325&oldid=2110895750"